Iondrive (ASX:ION) – Webinar Presentation
Dr Ebbe Dommisse – CEO – Iondrive Limited (ASX:ION) is an emerging leader in battery recycling technology, with a focus on lithium batteries.
Iondrive (ASX:ION) – Webinar Presentation Read More »
Dr Ebbe Dommisse – CEO – Iondrive Limited (ASX:ION) is an emerging leader in battery recycling technology, with a focus on lithium batteries.
Iondrive (ASX:ION) – Webinar Presentation Read More »
Simon Madder – Managing Director & CEO, Chairman – Prime Financial Group Limited (ASX:PFG) is an advice, capital and asset management firm with team members around the globe.
Prime Financial Group (ASX:PFG) – Webinar Presentation Read More »
Gold producer Regis Resources (ASX:RRL) has announced a full-year loss, driven by previously disclosed hedging costs, losses, and recent impairments to its under-development McPhillamys project in central western NSW. This news follows the company’s decision to abandon the McPhillamys project, withdraw its reserve estimate, and terminate its involvement. Regis revealed a net loss of $186.02
Environmental ruling forces Regis to abandon project Read More »
ANZ Bank (ASX:ANZ) has faced further regulatory scrutiny from the Australian Prudential Regulation Authority (APRA), this time over its handling of information and transactions involving Commonwealth Government bonds. In a statement on Friday, APRA announced a significant increase in its capital overlay penalty on ANZ, raising it by 50% to $750 million. This decision was
ANZ slapped with $750 million APRA penalty Read More »
Another positive update from NZ respiratory products group, Fisher & Paykel Healthcare (ASX:FPH), on Friday. The company was upbeat about the first half of the year and raised its full-year guidance. The medical devices company expects first-half revenue for the six months ending September to be in the range of approximately NZ$940 million to NZ$950
F&P Healthcare raises full-year guidance Read More »
To register for today’s webinar click here. Proteomics International Laboratories (ASX:PIQ), a pioneer in predictive diagnostics, announced groundbreaking results showing the PromarkerD predictive test can predict renal decline in type 1 diabetes. PromarkerD has been previously validated for predicting renal decline up to four years in advance in type 2 diabetes. Shares are trading 8.98
Australian shares are set to end a 10-day winning streak after opening lower, following a negative session on Wall Street. Investors are closely examining ASX earnings to gauge the market’s direction for the rest of the year. High-quality businesses with strong cost control have performed well, while those more susceptible to external cost factors have
ASX down 0.37% near noon: Aus shares set to end a 10-day winning streak Read More »
This week’s edition of Winston’s Weekly offers an in-depth look at the latest developments in property and financial markets. Hosted by Paul Sanger, with insights from Winston, the discussion covers the ongoing rally in U.S. equity markets, potential rate cuts, and the current state of the Australian property market. The episode also examines key earnings
Winston’s Weekly: Contrasting performances from Charter Hall & Dexus Read More »
The struggling Brisbane-based regional bank on Thursday unveiled a wholesale revamp of its business structure and operating systems in what appears to be a final gamble for the company. If this revamp fails, Bank of Queensland may be swallowed by a larger rival for prudential reasons (a bailout). The savings from the restructuring won’t start
Is this the last chance for Bank of Queensland? Read More »
Some analysts were looking for more than the 9% rise in annual net profit that Northern Star Resources (ASX:NST) reported for the year to June on Thursday. Net profit hit a record $639 million, but some analysts had been expecting a 15% rise in statutory after-tax earnings. This was a miss. However, the real story
Northern Star surges on gold price boom Read More »